Can an adult with type 2 diabetes who cannot tolerate metformin because of muscle pain and risk of lactic acidosis be switched to empagliflozin 10 mg taken once daily in the evening after a meal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, you can switch to empagliflozin 10 mg once daily in the evening after food

For an adult with type 2 diabetes who cannot tolerate metformin due to muscle pain and lactic acidosis risk, empagliflozin 10 mg once daily is an appropriate alternative, and it can be taken in the evening after a meal. 1

Rationale for Switching from Metformin

Metformin intolerance is a valid reason to discontinue the medication. While metformin is first-line therapy for type 2 diabetes 2, 3, it should be stopped when:

  • Gastrointestinal side effects are persistent and problematic 4
  • There is concern for lactic acidosis risk, particularly with renal impairment, acute illness, or conditions causing hypoperfusion 2, 5, 6
  • Muscle pain occurs (though this is less commonly reported than GI symptoms)

When metformin cannot be used, SGLT2 inhibitors like empagliflozin are strongly recommended as alternative first-line agents, particularly given their cardiovascular and renal protective benefits. 3

Empagliflozin Dosing and Timing

Standard Dosing

  • Starting dose: 10 mg once daily 7, 1
  • Can be increased to 25 mg daily if additional glycemic control is needed and eGFR ≥45 mL/min/1.73 m² 3, 7
  • Food does not significantly affect empagliflozin absorption - it can be taken with or without meals 1

Evening vs Morning Administration

Research specifically examining timing shows:

  • No clinically significant difference in efficacy between morning and evening dosing 8
  • Evening administration showed 35% longer time to peak concentration but similar overall drug exposure 8
  • Glucose excretion (the therapeutic effect) was comparable between morning and evening doses 8

Therefore, taking empagliflozin 10 mg in the evening after food is perfectly acceptable and will not compromise efficacy.

Key Considerations Before Starting

Renal Function Requirements

  • eGFR must be ≥20 mL/min/1.73 m² for initiation 3
  • For glycemic control specifically, FDA labeling suggests not initiating if eGFR <45 mL/min/1.73 m², though cardiovascular/renal benefits persist at lower eGFR 7, 1
  • Once started, empagliflozin can be continued as eGFR declines 3

Important Safety Warnings

Volume Depletion Risk:

  • Monitor for dehydration, particularly in elderly patients (>75 years), those on diuretics, or with low blood pressure 7, 2
  • Ensure adequate hydration, especially when starting therapy 3

Genital Mycotic Infections:

  • Occur in approximately 6% of patients (vs 1% with placebo) 3
  • More common in women than men 3
  • Most cases are mild and easily treated 9, 10
  • Daily hygiene measures can reduce risk 3

Urinary Tract Infections:

  • Rates are similar to placebo (9-11 per 100 patient-years) 9
  • Serious infections requiring hospitalization are rare (0.2-0.4%) 9

Euglycemic Ketoacidosis:

  • Rare but serious complication 2, 7
  • Higher risk with insulin deficiency, acute illness, reduced food intake, or surgery
  • Educate patient to seek immediate care if experiencing nausea, vomiting, abdominal pain, or malaise 3

Hypoglycemia Risk

  • Empagliflozin alone does not cause hypoglycemia 2, 9
  • If patient is on sulfonylureas or insulin, those medications may need dose reduction 7, 11

Advantages of Empagliflozin Over Metformin

Cardiovascular and Renal Benefits:

  • Proven reduction in cardiovascular death, heart failure hospitalization, and kidney disease progression 3, 7, 3
  • These benefits occur independent of glucose-lowering effects 3

Weight and Blood Pressure:

  • Modest weight loss (typically 2-3 kg) 2, 10, 12
  • Reduction in systolic blood pressure 2, 12

No Lactic Acidosis Risk:

  • Unlike metformin, empagliflozin does not carry risk of lactic acidosis 1

Monitoring After Initiation

  • Check renal function before starting and monitor periodically 3
  • Assess for volume depletion symptoms, especially in first weeks
  • Monitor for genital/urinary symptoms
  • Check HbA1c in 3 months to assess glycemic response 10, 13
  • If additional glucose lowering is needed, consider adding a GLP-1 receptor agonist 3, 11, 14

Common Pitfall to Avoid

Do not withhold empagliflozin solely based on older eGFR cutoffs. Current guidelines support initiation down to eGFR 20 mL/min/1.73 m² for cardiovascular and renal benefits 3, though glucose-lowering efficacy diminishes below eGFR 45 mL/min/1.73 m² 3, 2.

References

Related Questions

Can I continue empagliflozin (Jardiance) 10 mg once daily and metformin 1000 mg twice daily?
In a woman taking empagliflozin (SGLT2 inhibitor), metformin, and levothyroxine who began fluconazole yesterday on an every‑other‑day regimen and now has a markedly enlarged, painful clitoris, how should this be managed?
In a 38‑year‑old patient with type 2 diabetes, hypertension and hyperlipidemia who is taking empagliflozin 10 mg daily and metformin extended‑release (metformin XR) 2 g with the evening meal, is the metformin XR 2 g dose sufficient given fasting glucose ranging from 5.8 to 9 mmol/L?
In a patient with type 2 diabetes taking metformin, do tuberculosis drugs increase the risk of metformin-associated lactic acidosis?
Can I skip a dose of Jardiance (empagliflozin) for one day during a long trip if I anticipate difficulty urinating?
What is the appropriate management for a bowel that appeared viable during exploratory laparotomy but has deteriorated after 24 hours?
How should a patient with abdominal compartment syndrome and intra‑abdominal pressure of 25 mm Hg prior to re‑exploration be managed?
In a 1‑year‑old infant with a dry cough lasting more than four weeks, no fever, normal growth, normal physical examination, and normal chest X‑ray, should antibiotics be prescribed?
Are there studies supporting a planned second‑look laparotomy after the initial exploration showed viable bowel and tension‑free abdominal closure, despite the patient developing sepsis beyond the six‑hour golden period?
In a patient with a three‑day history of intestinal obstruction prior to the initial operation (exceeding the typical 6‑hour incarceration period), should a second‑look laparotomy be performed, and what is the optimal timing?
In chronic kidney disease, are low ferritin and hypercalcemia expected, and what are the differential diagnoses?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.